Pérez CJ, Pérez CLL, Pérez CLJ, García MMC, Jaramillo RY

Language: Spanish
References: 13
Page: 1-5
PDF size: 207.36 Kb.

ABSTRACT

Background: Whereas every year in our country is more than 10,000 new cases of cervical cancer and around 5000 woman dies, the impact of the detection programs, are still over expected, this despite extended daily coverage throughout the country.
Methods: The present study has as its fundamental purpose, to evaluate the quality cytological sample by two different interpretation techniques, based liquid and the traditional Pap, both samples were taken from the cervix transformation zone with a polyethylene brush. The study was conducted in 104 patients getting 208 samples. Both samples were processed and evaluated mainly cellular specimen quality of both techniques and subsequently comparing the results of each of the groups.
Results: We evaluated a total of 208 slides (104 patients) who underwent the making of a liquid and a traditional cytology. The middle age of the patients was 45.3 years. In the group of liquid based cytology slides 94.2% were validated as excellent for its content cell metaplasia and endocervical cells present, 5.8% were classified with good quality, in these samples were not detected lamellae absent from cellular material for diagnosis. For the traditional Papanicolaou, we found that the 36.5% of the samples where excellent; the 58% with satisfactory cellularity and 4.8% whit few material but enough to do the diagnosis, with this technique, there where no reports of needing material for a correct cytology diagnosis.
Conclusion: Sampling with the polyethylene brush in the cytological techniques and traditional liquid basis, enabled us to obtain in all cases the cellular material and endocervical transformation zone. This led us to significantly improve the quality of the slides, allowing more and better diagnosis of abnormal cells in institutional screening programs.

REFERENCES

1. WHO/ICO Information Centre on HPV and Cervical Cancer (HPV Information Centre) 2010

2. Parkin M, Almonte M, Bruni L. Magnitud y tendencias de las infecciones por tipos específicos del virus del papiloma humano de enfermedades relacionadas en America Latina y el Caribe. Vaccine pag. 2-16, Vol. 26, Supl 10- 2008

3. Gustafsson L, Ponten J, Bergstrom R, Adami HO.International incidence rates of invasive cervical cancer before cytological screening. Int J Cancer Causes Control.1997;71:159.

4. Parkin DM, Bray F. Chapter 2: The burden of HPV related cancers. Vaccine 2006;24(suppl 3):S3/11Y25

5. WHO/ICO Information Centre on HPV and Cervical Cancer (HPV Information Centre). Summary report on HPV and cervical cancer statistics in Mexico. 2007.

6. Alliance for Cervical Cancer Prevention (ACCP). The Case for Investing in Cervical Cancer Prevention. Seattle: ACCP; 2004.

7. Gold MA. Current cervical cancer screening guidelines and impact of prophylactic HPV vaccines. New Options in HPV Prevention. Supplement to OBG Management July 2006.

8. American Cancer Society website. Cervical cancer prevention. June 2006. Disponible en documents.cancer.org/115.00/115.00.pdf. Revisado en linea el 14 de mayo de 2007.

9. Centers for Disease Control and Prevention (CDC).The National Breast and Cervical Cancer Early Detection Program—reducing mortality through screening. Disponible en:www.cdc.gov/cancer/nbccedp 10 de mayo de 2007.

10. U.S. Preventive Services Task Force. Screening for cervical cancer: recommendations and rationale. In: Guide to Clinical Preventive Services. 3rd ed. Rockville, MD: Agency for Healthcare Research and Quality; 2003.

11. Nanda K, McCrory D, Myers ER, et al. Accuracy of the Papanicolaou test in screening for and followup of cervical cytologic abnormalities: A systematic review. Ann Intern Med 2000;132:810-819.

12. Arbyn M, Bergeron C, Klinkhamer P, Martin-Hirsch P, Siebers AG, Bulten J. Liquid compared with conventional cervical cytology: a systematic review and meta-analysis. Obstet Gynecol 2008;111:167Y77.

13. Siebers AG, Klinkhamer PJ, Grefte JM, et al. Comparison of liquid-based cytology with conventional cytology for detection of cervical cancer precursors: a randomized controlled trial. JAMA 2009;302:1757Y64.